Judy F. Gordon
Plus aucun poste en cours
Profil
Judy F.
Gordon is the founder of ClinReg Consulting Services, Inc. She previously worked as Head-Regulatory Affairs at Iconic Therapeutics, Senior Vice President-Regulatory Affairs at Glaukos Corp., and Senior Vice President-Research & Development at Chiron Vision Corp.
She holds a doctorate degree from Alma Mater Studiorum - Università di Bologna and an undergraduate degree from the University of California Los Angeles Graduate School.
Anciens postes connus de Judy F. Gordon
| Sociétés | Poste | Fin |
|---|---|---|
| GLAUKOS CORPORATION | Conseiller Juridique Général | - |
| Chiron Vision Corp. | Directeur Technique/Scientifique/R&D | - |
| ClinReg Consulting Services, Inc. | Fondateur | - |
Iconic Therapeutics, Inc.
 Iconic Therapeutics, Inc. BiotechnologyHealth Technology Iconic Therapeutics, Inc. engages in the development of novel therapeutics for the treatment of serious eye disorders. Its product ICON-1, is a novel immune-conjugate fusion protein that works with the body’s immune system to address the root causes of inflammation and angiogenesis together, potentially altering the course of causes of blindness. The company was founded by Alan Garen, Kirk Dornbush, and Michael I. Sherman in 2003 and is headquartered in South San Francisco, CA. | Conseiller Juridique Général | - |
Formation de Judy F. Gordon
| Alma Mater Studiorum - Università di Bologna | Doctorate Degree |
| University of California Los Angeles Graduate School | Undergraduate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| GLAUKOS CORPORATION | Health Technology |
| Entreprise privées | 3 |
|---|---|
Iconic Therapeutics, Inc.
Iconic Therapeutics, Inc. BiotechnologyHealth Technology Iconic Therapeutics, Inc. engages in the development of novel therapeutics for the treatment of serious eye disorders. Its product ICON-1, is a novel immune-conjugate fusion protein that works with the body’s immune system to address the root causes of inflammation and angiogenesis together, potentially altering the course of causes of blindness. The company was founded by Alan Garen, Kirk Dornbush, and Michael I. Sherman in 2003 and is headquartered in South San Francisco, CA. | Health Technology |
| Chiron Vision Corp. | |
| ClinReg Consulting Services, Inc. |
